You are here : health.am > Health Centers > Drug News
Drug News
COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals
• Drug News • Jul 27 06
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been the most popular treatment for arthritis - despite their association with gastrointestinal (GI) complications, including bleeding ulcers and…
Low-dose Glaxo bird flu vaccine seen ready in 2007
• Drug News • Jul 26 06
A bird flu vaccine for humans that uses only a very low dose of active ingredient has proved effective in clinical tests and could…
“Miracle” Cancer Drug Gleevec Can be Toxic to the Heart
• Drug News • Jul 23 06
Gleevec, the wildly successful poster-child of a new generation of cancer drugs aimed at specific targets in the cancer cell, can be dangerous to…
FDA Has Sweet News for Consumers of Sugar Substitutes
• Drug News • Jul 20 06
Sugar substitutes receive a strong endorsement this month from the U.S. Food and Drug Administration. The FDA has issued a fact sheet on sugar…
Drug industry laments G8 failure on vaccine plan
• Drug News • Jul 18 06
World leaders missed a major opportunity to boost basic health in poor countries this week when G8 leaders failed to adopt a lead vaccine…
Multiple Myeloma Oral Therapy REVLIMID Approved by FDA
• Drug News • Jul 18 06
The U.S. Food and Drug Administration (FDA) has approved REVLIMID® (lenalidomide) as a treatment for multiple myeloma, a type of blood cancer. The oral…
FDA approval for Gemzar for ovarian cancer
• Drug News • Jul 18 06
Eli Lilly and Company announced that the United States Food and Drug Administration (FDA) has approved Gemzar (gemcitabine HCl) for use in the treatment…
FDA approves Implanon (etonogestrel implant) contraceptive
• Drug News • Jul 18 06
Organon announced today that the U.S. Food and Drug Administration (FDA) approved Implanon (etonogestrel implant) 68mg, the first and only single-rod implantable contraceptive that…
Bayer’s takeover offer for Schering AG complete
• Drug News • Jul 13 06
Bayer’s public takeover offer for Schering AG has been completed. Following expiration of the additional acceptance period, Bayer now has control of 92.4 percent…
Online sexual enhancement products risky: FDA
• Drug News • Jul 13 06
Some sexual enhancement products sold on the Internet contain the same ingredients as prescription drugs such as Viagra and are not only illegal but…
FDA approves Atripla for the treatment of HIV-1 infection in adults
• Drug News • Jul 13 06
Bristol-Myers Squibb and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200…
FDA says open to more flexible clinical trials
• Drug News • Jul 11 06
U.S. regulators are preparing guidelines telling drug makers how they can streamline the testing of experimental medicines by conducting more flexible clinical trials, a…
Roswell Park research aids development of myeloma drug
• Drug News • Jul 11 06
Roswell Park Cancer Institute (RPCI) researchers played a leading role in clinical studies which led to U.S. Food and Drug Administration (FDA) approval of…
US report faults FDA post-approval study tracking
• Drug News • Jul 10 06
The U.S. Food and Drug Administration does not know the status of many post-approval studies promised by drug makers and does not make tracking…
FDA grants accelerated approval for Sprycel (dasatinib)
• Drug News • Jun 30 06
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for Sprycel (dasatinib), a new oral treatment for patients with chronic myeloid leukemia…
FDA approves Exelon to treat dementia of Parkinson’s disease
• Drug News • Jun 28 06
The Food and Drug Administration (FDA) has approved Exelon (rivastigmine tartrate) for the treatment of mild to moderate dementia (chronic loss or impairment of…
FDA gives tentative approval for generic pediatric AIDS drug
• Drug News • Jun 28 06
The Food and Drug Administration (FDA) today announced the tentative approval of the generic version of Abacavir Sulfate Oral Solution, 20 mg (base)/mL manufactured…
Forteo not cost-effective as first osteoporosis drug
• Drug News • Jun 15 06
Postmenopausal women with severe osteoporosis, a condition that makes bones porous and more likely to break, Forteo (teriparatide), the first in a new class…
Novartis diabetes drug effective in combo study
• Drug News • Jun 13 06
Vildagliptin, an investigational diabetes drug made by Novartis AG, significantly reduced blood sugar levels in patients with type 2 diabetes when given in combination…
FDA cracks down on fake drugs
• Drug News • Jun 12 06
A draft policy from the FDA’s counterfeit drug task force, concerns drugs marketed in the United States that do not have required FDA approval…
Lawsuits filed over Lipitor side effects
• Drug News • Jun 08 06
Two men who believe they suffered lasting muscle damage from taking the popular anti-cholesterol drug Lipitor are suing medication’s maker, Pfizer Inc., claiming the…
FDA official urged halt to Ketek trial on kids
• Drug News • Jun 08 06
A U.S. health official last month called for French drugmaker Sanofi-Aventis to halt clinical trials of its antibiotic Ketek in children because the drug…
Tuberculosis Drug May Cure Parkinson’s-Like Illness
• Drug News • Jun 07 06
Researchers have discovered that a drug used to treat tuberculosis apparently cures patients of a Parkinson’s-like illness suffered by thousands of mineworkers, welders and…
Schering says leukemia drug MabCampath promising
• Drug News • Jun 05 06
German drugmaker Schering AG and U.S. biotech firm Genzyme Corp have seen good preliminary results in a study of the drug MabCampath to treat…
Injectable Osteoporosis Drug Shows Promise
• Drug News • Jun 01 06
A new drug for osteoporosis increases bone mineral density and decreases the rate of bone destruction in postmenopausal women.
The findings, which appear in…